Stiefel, GlaxoSmithKline deal

By WIR Staff | Apr 27, 2009 | 7:00 AM GMT

GlaxoSmithKline will acquire dermatology company Stiefel for $2.9 billion in cash. Stiefel shareholders are eligible to receive up

Read the full 189 word article

How to gain access

Continue reading with a
two-week free trial.